The role of miRNA-29b1 on the hypoxia-induced apoptosis in mammalian cardiomyocytes.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Author(s): Dai B;Dai B; Liu H; Liu H; Juan D; Juan D; Wu K; Wu K; Cao R; Cao R
  • Source:
    European journal of histochemistry : EJH [Eur J Histochem] 2024 Jun 27; Vol. 68 (3). Date of Electronic Publication: 2024 Jun 27.
  • Publication Type:
    Journal Article
  • Language:
    English
  • Additional Information
    • Source:
      Publisher: PagePress Publications Country of Publication: Italy NLM ID: 9207930 Publication Model: Electronic Cited Medium: Internet ISSN: 2038-8306 (Electronic) Linking ISSN: 1121760X NLM ISO Abbreviation: Eur J Histochem Subsets: MEDLINE
    • Publication Information:
      Publication: Jan. 2010- : Pavia : PagePress Publications
      Original Publication: Pavia : Luigi Ponzio, [1992-
    • Subject Terms:
    • Abstract:
      Cardiomyocyte apoptosis is a complex biological process involving the interaction of many factors and signaling pathways. In hypoxic environment, cardiomyocytes may trigger apoptosis due to insufficient energy supply, increased production of oxygen free radicals, and disturbance of intracellular calcium ion balance. The present research aimed to investigate the role of microRNA-29b1 (miR-29b1) in hypoxia-treated cardiomyocytes and its potential mechanism involved. We established an in vitro ischemia model using AC16 and H9C2 cardiomyocytes through hypoxia treatment (1% O2, 48 h). Cell apoptosis was evaluated by flow cytometry using Annexin V FITC-PI staining assay. Moreover, we used Western blot and immunofluorescence analysis to determine the expression of Bcl-2, Bax caspase-3 and Cx43 proteins. We found that miR-29b1 protected AC16 and H9C2 cells from hypoxia-induced injury as evidence that miR-29b1 attenuated the effects of hypoxia treatment on AC16 and H9C2 cell apoptosis after hypoxia treatment. In conclusion, our findings suggest that miR-29b1 may have potential cardiovascular protective effects during ischemia-related myocardial injury.
    • References:
      J Neurol Sci. 2014 Feb 15;337(1-2):3-7. (PMID: 24300230)
      Circ Res. 1999 Nov 12;85(10):940-9. (PMID: 10559141)
      FASEB J. 2011 May;25(5):1718-28. (PMID: 21266537)
      Heart Fail Rev. 2016 Mar;21(2):157-67. (PMID: 26872675)
      J Pharmacol Exp Ther. 2009 Sep;330(3):670-8. (PMID: 19509316)
      Biochem Biophys Res Commun. 2009 Dec 4;390(1):38-43. (PMID: 19766591)
      Biochem J. 2009 Apr 15;419(2):261-72. (PMID: 19309313)
      Proc Natl Acad Sci U S A. 2008 Sep 2;105(35):13027-32. (PMID: 18723672)
      Circ J. 2016 Sep 23;80(10):2183-91. (PMID: 27593229)
      J Mol Cell Cardiol. 2011 Jun;50(6):1044-55. (PMID: 21420413)
      Cell Biochem Biophys. 2015 Mar;71(2):821-6. (PMID: 25308856)
      Apoptosis. 2005 Oct;10(5):1019-29. (PMID: 16151637)
      Stroke. 2013 Jun;44(6):e70. (PMID: 23592766)
      Biomed Pharmacother. 2019 Dec;120:109464. (PMID: 31590128)
      Proc Natl Acad Sci U S A. 1999 Jul 6;96(14):8144-9. (PMID: 10393962)
      Genes Dev. 2001 Nov 15;15(22):2922-33. (PMID: 11711427)
      FEBS Lett. 2003 Apr 24;541(1-3):1-5. (PMID: 12706809)
      Cardiovasc Res. 2008 Sep 1;79(4):562-70. (PMID: 18511432)
      Proc Natl Acad Sci U S A. 2008 Apr 15;105(15):5874-8. (PMID: 18390668)
      Circulation. 2016 Jan 26;133(4):e38-360. (PMID: 26673558)
      Med Hypotheses. 2008;70(1):52-5. (PMID: 17601679)
      Biochim Biophys Acta. 2012 Aug;1818(8):2020-9. (PMID: 21839722)
      EMBO Mol Med. 2016 Jun 01;8(6):643-53. (PMID: 27137489)
      Cell Death Dis. 2014 Sep 18;5:e1424. (PMID: 25232678)
      Cell Physiol Biochem. 2013;32(3):655-62. (PMID: 24029877)
      Int J Cardiol. 2013 Sep 30;168(2):934-45. (PMID: 23218570)
      Apoptosis. 2009 Apr;14(4):536-48. (PMID: 19142731)
      Biomed Res Int. 2015;2015:245412. (PMID: 26844226)
      Toxicol Sci. 2006 Jun;91(2):484-92. (PMID: 16531468)
      J Clin Invest. 2005 Oct;115(10):2610-7. (PMID: 16200193)
      N Engl J Med. 1996 Oct 17;335(16):1182-9. (PMID: 8815940)
      Heart Rhythm. 2012 Aug;9(8):1331-4. (PMID: 22133632)
      Biochem J. 2006 Mar 15;394(Pt 3):527-43. (PMID: 16492141)
      J Transl Med. 2016 Aug 27;14(1):248. (PMID: 27567668)
      Circ Res. 2011 Oct 28;109(10):1115-9. (PMID: 21903938)
      Circ Res. 2016 Apr 15;118(8):1208-22. (PMID: 26976650)
      J Clin Invest. 2012 Feb;122(2):497-506. (PMID: 22269326)
      J Mol Cell Cardiol. 2018 May;118:133-146. (PMID: 29608885)
      Cell Death Differ. 2009 Apr;16(4):524-36. (PMID: 19197295)
      Cell Death Differ. 2006 Oct;13(10):1707-14. (PMID: 16485029)
      Antioxid Redox Signal. 2013 Aug 1;19(4):400-14. (PMID: 22793879)
      J Lab Clin Med. 2003 Nov;142(5):288-97. (PMID: 14647032)
      Biol Chem. 2002 May;383(5):725-37. (PMID: 12108537)
      Head Neck. 2005 Sep;27(9):794-800. (PMID: 15952193)
      J Intern Med. 2005 Dec;258(6):479-517. (PMID: 16313474)
      Am J Physiol Heart Circ Physiol. 2010 Apr;298(4):H1115-25. (PMID: 20118409)
      Front Physiol. 2014 Feb 25;5:71. (PMID: 24611052)
      Ann Transl Med. 2016 Jul;4(13):256. (PMID: 27500157)
      J Membr Biol. 2012 Jun;245(5-6):275-81. (PMID: 22722763)
      Circ Res. 2012 Jan 20;110(2):312-24. (PMID: 22116819)
      J Neurosci. 2003 Jul 23;23(16):6413-22. (PMID: 12878681)
      Cell Death Differ. 2009 Jan;16(1):151-63. (PMID: 18820645)
    • Accession Number:
      0 (Connexin 43)
      0 (MicroRNAs)
      0 (MIRN29 microRNA, rat)
      0 (Proto-Oncogene Proteins c-bcl-2)
      0 (MIRN29B1 microRNA, human)
    • Publication Date:
      Date Created: 20240627 Date Completed: 20240627 Latest Revision: 20240710
    • Publication Date:
      20240710
    • Accession Number:
      PMC11228570
    • Accession Number:
      10.4081/ejh.2024.4021
    • Accession Number:
      38934067